The board of directors of the China NT Pharma Group Company Limited announced that based on a preliminary review of the Group's unaudited management accounts and the information currently available to the Board, the Board currently estimates that the Group will likely record a loss for the year ended 31 December 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 HKD | +4.17% | -3.85% | -54.55% |
Mar. 28 | China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 15 | China NT Pharma Group Company Limited Announces Directorate Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-54.55% | 8.12M | |
+18.71% | 44.35B | |
+19.48% | 15.08B | |
+19.49% | 14.37B | |
+57.58% | 13.06B | |
-0.05% | 6.79B | |
-9.70% | 6.75B | |
-8.87% | 5.73B | |
+13.66% | 5.64B | |
+4.00% | 4.66B |
- Stock Market
- Equities
- 1011 Stock
- News China NT Pharma Group Company Limited
- China NT Pharma Group Company Limited Provides Group Earnings Guidance for the Full Year Ended 31 December 2013